Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 743-756 , October 2007

Simplifications in analyzing positron emission tomography data: effects on outcome measures

  • Jean Logan

      Affiliations

    • Corresponding Author InformationCorresponding author. Chemistry Department, Bldg. 555, Brookhaven National Laboratory, Upton, NY 11973, USA. Tel.: +1 631 344 4391; fax: +1 631 344 7902.
    • ,
  • David Alexoff
    • ,
  • Aarti Kriplani

Received 26 March 2007 ,Revised 25 May 2007 ,Accepted 6 June 2007.

References 

  1. Logan J, Fowler J, Volkow N, Wang G, Ding Y, Alexoff D. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834–840
  2. Ichise M, Ballinger J. From graphical analysis to multilinear regression analysis of reversible radioligand binding. J Cereb Blood Flow Metab. 1996;16:750–752
  3. Lammertsma A, Hume S. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153–158
  4. Ichise M, Ballinger JR, Golan H, Vines D, Luong A, Tsai S, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med. 1996;37:513–520
  5. Ichise M, Toyama H, Innis R, Carson R. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271–1281
  6. Ichise M, Liow J, Lu J, Takano A, Model K, Toyama H, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096–1112
  7. Feng D, Wong K, Wu C, Siu W. A technique for extracting physiological parameters and the required input function simultaneously from PET image measurements: theory and simulation study. IEEE Trans Inf Technol Biomed. 1997;1:243–254
  8. Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46:1959–1972
  9. Patlak C, Blasberg R. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5:584–590
  10. Lammertsma A, Bench C, Hume S, Osman S, Gunn K, Brooks D, et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab. 1996;16:42–52
  11. Huang S. Anatomy of SUV: standardized uptake value. Nucl Med Biol. 2000;27:643–646
  12. Naganawa M, Kimura Y, Ishii K, Oda K, Ishiwata K, Matani A. Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis. IEEE Trans Biomed Eng. 2005;52:201–210
  13. Naganawa M, Kimura Y, Nariai T, Ishii K, Oda K, Manabe Y, et al. Omission of serial arterial blood sampling in neuroreceptor imaging with independent component analysis. Neuroimage. 2005;26:885–890
  14. Cumming P, Yokoi F, Chen A, Deep P, Dagher A, Reutens D, et al. Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse. 1999;34:124–134
  15. Lo J, Cumming J. Interaction between sedative premedicants and ketamine in man and in isolated perfused rat livers. Anesthesiology. 1975;43:307–312
  16. Ding Y, Lin K, Garza V, Carter P, Alexoff D, Logan J, et al. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse. 2003;50:345–352
  17. Ding Y, Lin K, Logan J. PET imaging of norepinephrine transporters. Curr Pharm Des. 2006;12:3831–3845
  18. Ding Y, Lin K, Logan J, Benveniste H, Carter P. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. J Neurochem. 2005;94:337–351
  19. Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J, Ma Y, et al. Decreased dopaminergic responsiveness in alcoholic subjects. J Nucl Med. 2007;48:100
  20. Logan J, Wang G-J, Telang F, Fowler JS, Alexoff D, Zabroski J, et al. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol. 2007;34
  21. Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J, Childress A-R, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci. 2006;26:6583–6588
  22. Volkow ND, Gur RC, Wang G-J, Fowler JS, Moberg PJ, Ding Y-S, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry. 1998;155:344–349
  23. Gunn R, Lammertsma A, Hume S, Cunningham V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279–287
  24. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol. 2000;27:661–670
  25. Aston-Jones G, Rajkowski J, Kubiak P, Alexinsky T. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci. 1994;14:4467–4480
  26. Logan J, Ding Y, Lin K, Pareto D, Fowler J, Biegon A. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. Nucl Med Biol. 2005;32:531–542
  27. Volkow ND, Wang G-J, Ma Y, Fowler JS, Wong C, Ding Y-S, et al. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci. 2005;25:3932–3939
  28. Wang G-J, Yang J, Volkow ND, Telang F, Ma Y, Zhu W, et al. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A. 2006;103:15641–15645
  29. Jeong H-J, Chung J-K, Kim YK, Kim CY, Kim DG, Jeong JM, et al. Usefulness of whole-body 18F-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med. 2002;43:1432–1437
  30. Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med. 1997;38:802–808
  31. Hawkins RA, Choi Y, Huang S-C, Messa C, Hoh CK, Phelps ME. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med. 1992;33:339–344
  32. Mosconi L, Pupi A, De Cristofaro MTR, Fayyaz M, Sorbi S, Herholz K, et al. Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. J Nucl Med. 2004;45:382–392
  33. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med. 2001;42:548–557
  34. Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, et al. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med. 2005;46:936–944
  35. Chen WP, Matsunari I, Noda A, Yanase D, Yajima K, Takeda N, et al. Rapid scanning protocol for brain 18F-FDG PET: a validation study. J Nucl Med. 2005;46:1633–1641
  36. de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET). PNAS. 2001;98:10966–10971
  37. Sokoloff L, Reivich M, Kennedy C, Des Rosiers M, Patlak C, Pettigrew K, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897–916
  38. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol Endocrinol Metab. 1980;238:E69–E82
  39. Phelps M, Huang S, Hoffman E, Selin C, Sokoloff L, Kuhl D. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol. 1979;6:371–388
  40. Eberl S, Anayat A, Fulton R, Hooper P, Fulham M. Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur J Nucl Med. 1997;24:299–304
  41. Bentourkia M, Bol A, Michel C, Coppens A, Sibomana M, De Volder AG. A simplified blood sampling scheme in FDG-PET studies. Nuclear Science Symposium IEEE 1997;2:1711–5.
  42. Wakita K, Imahori Y, Ido T, Fujii R, Horii H, Shimizu M, et al. Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method. J Nucl Med. 2000;41:1484–1490
  43. Bonson KR, Grant SJ, Links JM, London ED. Validation of an analytic method of calculating cerebral glucose metabolism using PET. J Nucl Med. 2000;41:658–660
  44. Bentourkia M. Kinetic modeling of PET_FDG in the brain without blood sampling. Computerized Medical Imaging and Graphics (wwwScienceDirectcom) 2006.
  45. Fowler J, Wolf A, MacGregor R, Dewey S, Logan J, Schlyer D, et al. Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]l-deprenyl in living baboon brain. J Neurochem. 1988;51:1524–1534
  46. Fowler J, Volkow N, Wang G, Pappas N, Shea C, MacGregor R, et al. Visualization of monoamine oxidase in human brain. Adv Pharmacol. 1998;42:304–307
  47. Fowler J, Logan J, Wang G, Volkow N, Telang F, Ding Y, et al. Comparison of the binding of the irreversible monoamine oxidase tracers, [(11)C]clorgyline and [(11)C]l-deprenyl in brain and peripheral organs in humans. Nucl Med Biol. 2004;31:313–319
  48. Fowler J, Logan J, Volkow N, Wang G, MacGregor R, Ding Y. Monoamine oxidase: radiotracer development and human studies. Methods. 2002;27:263–277
  49. Fowler J, Logan J, Volkow N, Wang G. Translational neuroimaging: positron emission tomography studies of monoamine oxidase. Mol Imaging Biol. 2005;7:377–387
  50. Kriplani A, Schlyer D, Logan J, Fowler J. Consequences of partial volume effects and spillover in image derived input functions. 2005;
  51. Kriplani A, Stoll SP, Southekal S, Schlyer DJ, Park SJ, Villanueva A, et al. Noninvasive high-resolution detection of the arterial and venous input function through a PET wrist scanner. Nuclear Science Symposium Conference Record IEEE 2005:2240–4.
  52. Kriplani A, Schlyer DJ, Vaska P, Stoll SP, Southekal S, Park SJ, et al. Non-Invasive and Selective Measurement of the Arterial Input Function Using a PET Wrist Scanner. Nuclear Science Symposium and Medical Imaging Conference Record 2006 IEEE 2006:3266–70.

☆ This work was carried out at Brookhaven National Laboratory under Contract No. DE-AC02-98CH10886 with the U.S. Department of Energy and supported by its Office of Biological and Environmental Research.

PII: S0969-8051(07)00163-1

doi: 10.1016/j.nucmedbio.2007.06.003

Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 743-756 , October 2007

Article Tools

* Image Usage & Resolution